ISPOR - PRO8 Analysis of Health Authorities Collaboration for Orphan Drug Designation and Their IMPACT on the Growth of Orphan Drug Market

PRO8 Analysis of Health Authorities Collaboration for Orphan Drug Designation and Their IMPACT on the Growth of Orphan Drug Market

Abstract

Authors

G. Mishra

Full Text Cite This Article

Back to Volume 22, Supplemental S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now